Data / Form D filings / Immutrix Therapeutics, Inc.
Immutrix Therapeutics, Inc.: Form D filings
Immutrix Therapeutics, Inc., a company in Rapid City, SD, filed 8 Form D notices with the SEC between 2015 and 2025. The latest, on September 22, 2025, reports $480,000 sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3620 HOMESTEAD STREET, Rapid City, SD, 57703
- Phone
- (605) 721-7979
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- South Dakota
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1656200
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | New notice | $5,000,000 | $480,000 | $4,520,000 | 1 | Sep 18, 2025 | sec.gov |
| Jul 14, 2020 | New notice | $15,000,000 | $300,000 | $14,700,000 | 1 | Jul 1, 2020 | sec.gov |
| Sep 5, 2019 | New notice | $2,000,000 | $450,000 | $1,550,000 | 2 | Aug 31, 2019 | sec.gov |
| Oct 12, 2018 | Amendment | $16,000,000 | $5,277,500 | $10,722,500 | 26 | Nov 13, 2017 | sec.gov |
| Nov 27, 2017 | New notice | $12,000,000 | $200,000 | $11,800,000 | 1 | Nov 13, 2017 | sec.gov |
| Jul 22, 2016 | Amendment | $5,000,000 | $4,089,850 | $910,150 | 34 | Jun 4, 2014 | sec.gov |
| Jun 28, 2016 | New notice | $5,000,000 | $2,925,000 | $2,075,000 | 22 | Jun 4, 2014 | sec.gov |
| Oct 20, 2015 | New notice | $6,500,000 | $3,900,000 | $2,600,000 | 1 | Oct 16, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dan L Smith | Executive Officer | |
| Brad L Hennrich | Director | |
| Rich L Otto | Director | |
| Carol L Rae | Director | |
| Lonnie Lien Bookbinder | Director | |
| Ronald L Shape | Executive Officer, Director | |
| Stephanie Lien D'Urso | Director | |
| Russell Lien McCulloh | Director |
Every Form D from the week of Sep 22, 2025 · All recent filings in South Dakota · All recent Other filings
Read from SEC EDGAR. Amount sold is what Immutrix Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.